Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brentuximab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03947255
What this trial is testing

Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma

Who this might be right for
Hodgkin LymphomaPeripheral T Cell LymphomaAnaplastic Large Cell Lymphoma
Seagen Inc. 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT02979522
What this trial is testing

Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma

Who this might be right for
Hodgkin Disease
Takeda 59
Not applicableStudy completedNCT06295211
What this trial is testing

Brentuximab Vedotin Combined With Bendamustine Supercharge, a Low-toxicity and Efficient Salvage Regimen for Primary Refractory or First-relapsed Classic Hodgkin Lymphoma: Long-term Results of a Retrospective Monocenter Study.

Who this might be right for
Hodgkin Lymphoma
Federico II University 32
Not applicableLooking for participantsNCT05100056
What this trial is testing

Brentuximab Vedotin in Adults With Hodgkin's Lymphoma

Who this might be right for
Hodgkin Lymphoma
Takeda 70
Testing effectiveness (Phase 2)Ended earlyNCT02499627
What this trial is testing

Bendamustine Plus Brentuximab Vedotin in HL and CD30+ PTCL in First Salvage Setting

Who this might be right for
Lymphatic Diseases
Fondazione Italiana Linfomi - ETS 43
Testing effectiveness (Phase 2)Looking for participantsNCT05357794
What this trial is testing

Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides

Who this might be right for
Mycosis Fungoides
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05922904
What this trial is testing

PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT05673785
What this trial is testing

Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)

Who this might be right for
Lymphoma
Takeda 52
Testing effectiveness (Phase 2)Study completedNCT03246750
What this trial is testing

B-MAD Chemotherapy in Newly-diagnosed Extranodal NK/ T-cell Lymphoma

Who this might be right for
Extranodal NK/T-cell Lymphoma
The Thai Lymphoma Study Group 34
Not applicableStudy completedNCT04837222
What this trial is testing

Brentuximab Vedotin in Adults With CD30-positive Lymphoma

Who this might be right for
Lymphoma
Takeda 1,000
Testing effectiveness (Phase 2)Ended earlyNCT02169505
What this trial is testing

Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT)

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 2
Large-scale testing (Phase 3)Active Not RecruitingNCT04404283
What this trial is testing

Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
Seagen, a wholly owned subsidiary of Pfizer 239
Early research (Phase 1)Study completedNCT02616965
What this trial is testing

Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma

Who this might be right for
Cutaneous T-cell Lymphoma (CTCL)
Fox Chase Cancer Center 16
Early research (Phase 1)Study completedNCT03302728
What this trial is testing

Brentuximab Vedotin and Lenalidomide in Patients With Relapsed/ Refractory T-cell Lymphoma or Hodgkin Lymphoma

Who this might be right for
Lymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralHodgkin Lymphoma
Peter MacCallum Cancer Centre, Australia 6
Testing effectiveness (Phase 2)Study completedNCT01874054
What this trial is testing

Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma

Who this might be right for
Hodgkin Disease
Seagen Inc. 55
Post-approval studies (Phase 4)Study completedNCT01990534
What this trial is testing

Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Millennium Pharmaceuticals, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT03409432
What this trial is testing

Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma

Who this might be right for
Lymphomatoid PapulosisPrimary Cutaneous Anaplastic Large Cell LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma+6 more
John Reneau 26
Testing effectiveness (Phase 2)Study completedNCT01780662
What this trial is testing

Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Recurrent Adult Hodgkin LymphomaRecurrent Childhood Hodgkin LymphomaRefractory Childhood Hodgkin Lymphoma
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Study completedNCT02505269
What this trial is testing

Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Massachusetts General Hospital 34
Testing effectiveness (Phase 2)Study completedNCT03652441
What this trial is testing

Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
University of Cologne 14
Next Page